Apoptosis: Inhibitor or Instigator of Carcinogenesis?

References

• Corcoran G. B., Ray S. D. The role of the nucleus and other compartments in toxic cell death produced by alkylating hepatotoxicants. Toxicol Appl Pharmacol 1992; 113: 167–183
   PubMed Web of Science ®Google Scholar
• Walker N. I., Harmon B. V., Kerr J. FR. Patterns of cell death. Methods Arch Exp Pathol 1988; 13: 144–159
   PubMedGoogle Scholar
• Kerr J. F., Wyllie A. H., Currie A. R. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239–527
   PubMed Web of Science ®Google Scholar
• Seale J., Kerr J. FR, Bishop C. J. Necrosis and apoptosis: Distinct modes of cell death with fundamentally different significance. Pathol Ann 1982; 17: 229–259
   Google Scholar
• Vaux D. L. Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci USA 1993; 90: 786–789
   PubMed Web of Science ®Google Scholar
• Raff M. C. Social controls on cell survival and cell death. Nature 1992; 356: 397–400
   PubMed Web of Science ®Google Scholar
• Arends M. J., Morris R. G., Wyllie A. H. Apoptosis: The role of the endonuclease. Am I Pathol 1990; 136: 593–608
   PubMed Web of Science ®Google Scholar
• Wyllie A. H., Kerr J. FR, Currie A. R. Cell death: The significance of apoptosis. Int Rev Cytol 1980; 68: 251–306
   PubMedGoogle Scholar
• Kerr J. FR, Harmon B. V. Definition and incidence of apoptosis: An historical perspective. Apoptosis: The Molecular Basis of Cell Death, L. D. Tomei, F. O. Cope. Cold Spring Harbor Press, Plainview, NY 1991; 5–29
   Google Scholar
• Gerschenson L. E., Rotello R. J. Apoptosis: A different type of cell death. FASEB J 1992; 6: 2450–2455
   PubMed Web of Science ®Google Scholar
• Booth C., Koch G. LE. Perturbation of cellular calcium induces secretion of luminal ER proteins. Cell 1989; 59: 729–737
   PubMed Web of Science ®Google Scholar
• Compton M. M. A biochemical hallmark of apoptosis: Internu-cleosomal degradation of the genome. Cancer Metast Rev 1992; 11: 105–119
   PubMed Web of Science ®Google Scholar
• Peitsch M. C., Polzar B., Stephan H., et al. Characterization of the endogenous deoxyribonuclease involved in nuclear DN A degradation during apoptosis (programmed cell death). EMBO J 1993; 12: 371–377
   PubMed Web of Science ®Google Scholar
• Barry M. A., Eastman A. Identification of deoxyribonuclease II as an endonuclease involved in apoptosis. Arch Biochem Biophys 1993; 300: 440–450
   PubMed Web of Science ®Google Scholar
• Barry M. A., Eastman A. Endonuclease activation during apoptosis: The role of cytosolic Ca2+ and pH. Biochem Biophys Res Commun 1992; 186: 782–789
   PubMed Web of Science ®Google Scholar
• Lennon S. V., Kilfeather S. A., Hallett M. B., et al. Elevations in cytosolic free Ca2+ are not required to trigger apoptosis in human leukaemia cells. Clin Exp Immunol 1992; 87: 465–471
   PubMed Web of Science ®Google Scholar
• Rice W. G., Hillyer C. D., Harten B., et al. Induction of endonuclease-mediated apoptosis in tumor cells by C-nitroso-substituted ligands of poly(ADP-ribose) polymerase. Proc Natl Acad Sci USA 1992; 89: 7703–7707
   PubMed Web of Science ®Google Scholar
• Negri C., Bernardi R., Braghetti A., et al. The effect of the chemotherapeutic drug VP-16 on poly(ADP)ribosylation in apoptotic HeLa cells. Carcinogenesis 1993; 14: 2559–2264
   PubMed Web of Science ®Google Scholar
• Venkatachalam S., Denissenko M. F., Wani A. A. Rapid activation of apoptosis in human leukemic cells by (+/−)-anti-benzo[a]pyrene diol epoxide induced DNA damage. Biochem Biophys Res Commun 1993; 197: 722–729
   PubMed Web of Science ®Google Scholar
• Ding R., Smulson M. Depletion of nuclear poly(ADP-ribose) polymerase by antisense RNA expression: Influences on genomic stability, chromatin organization, and carcinogen cytotoxicity. Cancer Res 1994; 54: 4627–4634
   PubMed Web of Science ®Google Scholar
• Evans D. L., Dive C. Effects of cisplatin on induction of apoptosis in proliferating hepatoma cells and nonproliferating immature thymocytes. Cancer Res 1993; 53: 2133–2139
   PubMed Web of Science ®Google Scholar
• Onishi Y., Azuma Y., Sata Y., et al. Topoisomerase inhibitors induce apoptosis in thymocytes. Biochim Biophys Acta 1993; 1175: 147–154
   PubMed Web of Science ®Google Scholar
• Dispasquale B., Youle R. J. Programmed cell death in heterokaryons. Am J Pathol 1992; 141: 1471–1479
   PubMed Web of Science ®Google Scholar
• Ghibelli L., Oliverio N. S., Piacentini M., et al. Cycloheximide can rescue heat-shocked L cells from death by blocking stress-induced apoptosis. Exp Cell Res 1992; 201: 436–443
   PubMed Web of Science ®Google Scholar
• Lin J.-K., Chou C.-K. In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor β1. Cancer Res 1992; 52: 385–388
   PubMed Web of Science ®Google Scholar
• Forbes I. J., Zalewski P. D., Giannakis C., et al. Induction of apoptosis in chronic lymphocytic leukemia cells and its prevention by phorbol ester. Exp Cell Res 1992; 198: 367–372
   PubMed Web of Science ®Google Scholar
• Blankenship L. J., Manning F. CR, Orenstein J. M., et al. Apoptosis is the mode of death caused by carcinogenic chromium. Toxicol Appl Pharmacol 1994; 126: 75–83
   PubMed Web of Science ®Google Scholar
• Manchester K. M., Heston W. DW, Donner D. B. Tumour necrosis factor-induced cytotoxicity is accompanied by intracellular mitogenic signals in ME-180 human cervical carcinoma cells. Biochem J 1993; 290: 185–190
   PubMed Web of Science ®Google Scholar
• Bazar L. S., Deeg H. J. Ultraviolet B-induced DNA fragmentation (apoptosis) in activated T-lymphocytes and Jurkat cells is augmented by inhibition of RNA and protein synthesis. Exp Hematol 1992; 20: 80–86
   PubMed Web of Science ®Google Scholar
• Ledda-Columbano G. M., Coni P., Faa G., et al. Rapid induction of apoptosis in rat liver by cycloheximide. Am J Pathol 1992; 140: 545–549
   PubMed Web of Science ®Google Scholar
• Collins R. J., Harmon B. V., Souvlis T., et al. Effects of cycloheximide on B-chronic lymphocytic leukaemia and normal lymphocytes in vitro: Induction of apoptosis. Br J Cancer 1991; 64: 518–522
   PubMed Web of Science ®Google Scholar
• Martin S. J., Lennon S. V., Bonham A. M., et al. Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J Immunol 1990; 145: 1859–1867
   PubMed Web of Science ®Google Scholar
• Song Q., Baxter G. D., Kovacs E. M., et al. Inhibition of apoptosis in human tumour cells by okadaic acid. J Cell Physiol 1992; 153: 550–556
   PubMed Web of Science ®Google Scholar
• Sarin A., Adams D. H., Henkart P. A. Protease inhibitors selectively block T cell receptor-triggered programmed cell death in a murine T cell hybridoma and activated peripheral T cells. J Exp Med 1993; 178: 1693–1700
   PubMed Web of Science ®Google Scholar
• Shi L., Kraut R. P., Aebersold R., et al. A natural killer cell granule protein that induces DNA fragmentation and apoptosis. J Exp Med 1992; 175: 553–566
   PubMed Web of Science ®Google Scholar
• Jarvis W. D., Koelsnick R. N., Fornari F. A., et al. Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc Natl Acad Sci USA 1994; 91: 73–77
   PubMed Web of Science ®Google Scholar
• Obeid L. M., Linardic C. M., Karolak L. A., et al. Programmed cell death induced by ceramide. Science 1993; 259: 1769–1771
   PubMed Web of Science ®Google Scholar
• Hannun Y. A., Linardic C. M. Sphingolipid breakdown products: anti-proliferative and tumor suppressor lipids. Biochim Biophys Acta 1993; 1154: 223–236
   PubMed Web of Science ®Google Scholar
• Linardic C. M., Jayadev S., Hannun Y. A. Brefeldin A promotes hydrolysis of sphingomyelin. J Biol Chem 1992; 267: 14909–14911
   PubMed Web of Science ®Google Scholar
• Barry M. A., Behnke C. A., Eastman A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins, and hyperthermia. Biochem Pharm 1990; 40: 2353–2362
   PubMed Web of Science ®Google Scholar
• Ijiri K. Apoptosis (cell death) induced in mouse bowel by 1,2-dimethylhydrazine, methylazoxymethanol acetate, and gamma radiation. Cancer Res 1989; 49: 6342–6346
   PubMed Web of Science ®Google Scholar
• Potten C. S., Li Y. Q., O'Connor P. J., et al. A possible explanation for the differential cancer incidence in the intestine, based on distribution of the cytotoxic effects of carcinogens in the murine large bowel. Carcinogenesis 1992; 13: 2305–2312
   PubMed Web of Science ®Google Scholar
• Muschel R. J., Zhang H. B., Iliakis G., et al. Cyclin B expression in HeLa cells during the G2 block induced by ionizing radiation. Cancer Res 1991; 51: 5113–5117
   PubMed Web of Science ®Google Scholar
• Warters R. L. Radiation-induced apoptosis in a murine T-cell hybridoma. Cancer Res 1992; 52: 883–890
   PubMed Web of Science ®Google Scholar
• Hardin J. A., Hinoshita F., Scherr D. H. Mechanisms by which benzo[a]pyrene, an environmental carcinogen, suppresses B cell lymphopoiesis. Toxicol Appl Pharmacol 1992; 117: 155–164
   PubMed Web of Science ®Google Scholar
• Manning F. CR, Blankenship L. J., Wise J. P., et al. Induction of internucleosomal DNA fragmentation by carcinogenic chromate: Relationship to DNA damage, genotoxicity, and inhibition of macromolecular synthesis. Environ Health Perspect 1994; 102(Suppl 3)159–167
   PubMed Web of Science ®Google Scholar
• Solary E., Bertrand R., Kohn K. W., et al. Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors. Blood 1993; 81: 1359–1368
   PubMed Web of Science ®Google Scholar
• Columbel M., Olsson C. A., Ng P.-Y., et al. Hormone-regulated apoptosis results from reentry of differential prostate cells into a defective cell cycle. Cancer Res 1992; 52: 4313–4319
   PubMed Web of Science ®Google Scholar
• Hickman J. A. Apoptosis induced by anticancer drugs. Cancer Metast Rev 1992; 11: 121–129
   PubMed Web of Science ®Google Scholar
• Chromium, Nickel, Welding. IARC monographs on the evaluation of carcinogenic risks to humans. IARC, LyonFrance 1990; 49
   Google Scholar
• The chromium problem: Research needs and risk assessment. Environ Health Perspect 92, C. Witmer, 1991
   Google Scholar
• Manning F. CR, Xu J., Patierno S. R. Transcriptional inhibition by carcinogenic chromate: Relationship to DNA damage. Mol Carcinogen 1992; 6: 270–279
   PubMed Web of Science ®Google Scholar
• Sugiyama M., Patierno S. R., Cantoni O., et al. Characterization of DNA lesions induced by CaCrCO4 in synchronous and asynchronous cultured mammalian cells. Mol Pharmacol 1986; 29: 606–613
   PubMed Web of Science ®Google Scholar
• Sugiyama M., Wang X. W., Costa M. Comparison of DNA lesions and cytotoxicity induced by calcium chromate in human, mouse, and hamster cell lines. Cancer Res 1986; 46: 4547–4551
   PubMed Web of Science ®Google Scholar
• Hamilton J. W., Wetterhahn K. E. Chromium (VI)-induced DNA damage in chick embryo liver and blood cells in vivo. Carcinogenesis 1986; 7: 2085–2088
   PubMed Web of Science ®Google Scholar
• Xu J., Wise J. P., Patierno S. R. DNA damage induced by carcinogenic lead chromate particles. Mutat Res 1992; 280: 129–136
   PubMed Web of Science ®Google Scholar
• Wise J. P., Leonard J. C., Patierno S. R. Clastogenicity of lead chromate particles in hamster and human cells. Mutat Res 1992; 278: 69–79
   PubMed Web of Science ®Google Scholar
• Levy L. S., Venitt S. Carcinogenicity and mutagenicity of chromium compounds: The association between bronchial metaplasia and neoplasia. Carcinogenesis 1986; 7: 831–835
   PubMed Web of Science ®Google Scholar
• Patierno S. R., Banh D., Landolph J. R. Transformation of C3H/ 10T1/2 mouse embryo cells to focus formation and anchorage independence by insoluble lead chromate but not soluble calcium chromate: Relationship to mutagenesis and internalization of lead chromate particles. Cancer Res 1988; 48: 5280–5288
   PubMed Web of Science ®Google Scholar
• Wise J. P., Orenstein J.-M., Patierno S. R. Inhibition of chromate clastogenesis by ascorbate: Relationship to particle dissolution and uptake. Carcinogenesis 1993; 14: 429–434
   PubMed Web of Science ®Google Scholar
• Wise J. P., Stearns D. M., Wetterhahn K. E., et al. Cell-enhanced dissolution of carcinogenic lead chromate particles: The role of individual dissolution products in clastogenesis. Carcinogenesis 1994; 15: 2249–2254
   PubMed Web of Science ®Google Scholar
• Standeven A. M., Wetterhahn K. E. Ascorbate is the principal intracellular reductant of chromium(VI) in rat liver and kidney ultrafiltrates. Carcinogenesis 1991; 12: 1733–1737
   PubMed Web of Science ®Google Scholar
• De Flora S., Wetterhahn K. E. Mechanisms of chromium metabolism and genotoxicity. Life Chem Rep 1989; 7: 169–244
   Google Scholar
• Bridgewater L. C., Manning F. CR, Woo E. S., et al. DNA polymerase arrest by adducted trivalent chromium. Mol Carcinogen 1994; 9: 122–133
   PubMed Web of Science ®Google Scholar
• Standeven A. M., Wetterhahn K. E. Is there a role for reactive oxygen species in the mechanism of chromium(VI) Carcinogenesis. Chem Res Toxicol 1991; 4: 616–625
   PubMed Web of Science ®Google Scholar
• Jones P., Kortenkamp A., O'Brien P., et al. Evidence for the generation of hydroxyl radicals from a chromium(V) intermediate isolated from the reaction of chromate with glutathione. Arch Biochem Biophys 1991; 286: 652–655
   PubMed Web of Science ®Google Scholar
• Patierno S. R., Blankenship L. J., Wise J. P., . Genotoxin-induced apoptosis: Implications for Carcinogenesis. The Cell Cycle: Regulators, Targets, and Clinical Applications, V. H. Hu, et al. Plenum Press, New York 1994; 331–340
   Google Scholar
• Xu J., Manning F. CR, PatiernoSR. Preferential formation andrepair of chromium-induced DNA adducts and DNA-protein crosslinks in nuclear matrix DNA. Carcinogenesis 1994; 15: 1443–1450
   PubMedGoogle Scholar
• Bridgewater L. C., Manning F. CR, Patierno S. R. Base-specific arrest by carcinogenic chromium: Relationship to DNA interstrand crosslinking. Carcinogenesis 1994; 15: 2421–2427
   PubMed Web of Science ®Google Scholar
• Sen S., D'Incalci M. Biochemical events and relevance to cancer chemotherapy. FEES Lett 1992; 307: 122–127
   PubMed Web of Science ®Google Scholar
• Ledda-Columbano G. M., Columbano A. Apoptosis and hepatocar-cinogenesis. Apoptosis: The Molecular Basis of Cell Death, L. D. Tomei, F. O. Cope. Cold Spring Harbor Press, Plainview, NY 1991; 101–119
   Google Scholar
• Lin Y. Q., Fan C. Y., O'Connor P. J., et al. Target cells for the cytotoxic effects of carcinogens in the murine small bowel. Carcinogenesis 1992; 13: 361–368
   PubMed Web of Science ®Google Scholar
• Potten C. S., Merritt A., Hickman J., et al. Characterization of radiation-induced apoptosis in the small intestine and its biological implications. Int J Radial Biol 1994; 65: 71–78
   PubMed Web of Science ®Google Scholar
• Merritt A. J., Potten C. S., Kemp C. J., et al. The role of p53 inspontaneous and radiation-induced apoplosis in the gastroinlestinal tract of normal and p53-deficient mice. Cancer Res 1994; 54: 614–617
   PubMed Web of Science ®Google Scholar
• Tomei L. D., Ranter P., Wenner C. E. Inhibition of radiation-induced apoptosis in vitro by tumor promoters. Biochem Biophys Res Commun 1988; 155: 324–331
   PubMed Web of Science ®Google Scholar
• Baxter G. D., Lavin M. F. Specific protein dephosphorylation in apoptosis induced by ionizing radiation and heat shock in human lymphoid tumor cells. J Immunol 1992; 148: 1949–1954
   PubMed Web of Science ®Google Scholar
• Hunter T. A thousand and one protein kinases. Cell 1987; 50: 823–829
   PubMed Web of Science ®Google Scholar
• Bursch W., Oberhammer F., Jirtle R. L., et al. Transforming growth factor-β1 as a signal for induction of cell death by apoptosis. Br J Cancer 1993; 67: 531–536
   PubMed Web of Science ®Google Scholar
• Schulte-Hermann R., Timmermann-Trosiener I., Barthel G., et al. DNA synthesis, apoplosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res 1990; 50: 5127–5135
   PubMed Web of Science ®Google Scholar
• Garcea R., Daino L., Pascale R., et al. Inhibition of promotion and persistent nodule growth by S-adenosyl-l-methionine in rat liver Carcinogenesis: Role of remodeling and apoplosis. Cancer Res 1989; 49: 1850–1856
   PubMed Web of Science ®Google Scholar
• Bursch W., Paffe S., Putz B., et al. Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis 1990; 11: 847–853
   PubMed Web of Science ®Google Scholar
• Cory S. Activation of cellular oncogenes in hematopoielic cells by chromosome translocation. Adv Cancer Res 1986; 47: 189–234
   PubMed Web of Science ®Google Scholar
• Vaux D. L., Cory S., Adams J. M. bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335: 440–442
   PubMed Web of Science ®Google Scholar
• Baffy G., Miyashita T., Williamson J. R., et al. Apoptosis induced by withdrawal of interleukin-3(IL-3) from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oucoprotein production. J Biol Chem 1993; 268: 6511–6519
   PubMed Web of Science ®Google Scholar
• Alnemri E. S., Fernandes T. F., Haldar S., et al. Involvement of BCL-2 in glucocorticoid-induced apoplosis of human pre-B-leukemias. Cancer Res 1992; 52: 491–495
   PubMed Web of Science ®Google Scholar
• Miyashita T., Reed C. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 1993; 81: 151–157
   PubMed Web of Science ®Google Scholar
• Hockenberry D., Nunez G., Milliman C., et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334–336
   PubMed Web of Science ®Google Scholar
• Mah S. P., Zhong L. T., Liu Y., et al. The protooncogene bcl-2 inhibits apoptosis in PC12 cells. J Neurochem 1993; 60: 1183–1186
   PubMed Web of Science ®Google Scholar
• Garcia I., Martinou I., Tsujimoto Y., et al. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science 1992; 258: 302–304
   PubMed Web of Science ®Google Scholar
• Korsmeyer S. J. bcl-2: An antidote to programmed cell death. Cancer Surv 1992; 15: 105–118
   PubMedGoogle Scholar
• Williams G. T. Programmed cell death: Apoplosis and oncogenesis. Cell 1991; 65: 1097–1098
   PubMed Web of Science ®Google Scholar
• Wagner A. J., Small M. B., Hay N. myc-mediated apoptosis is blocked be ectopic expression of bcl-2. Mol Cell Biol 1993; 13: 2432–2440
   PubMed Web of Science ®Google Scholar
• Bissomiette R. P., Echeverri F., Mahboubi A., et al. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 1992; 359: 552–554
   PubMed Web of Science ®Google Scholar
• Evan G. I., Wyllie A. H., Gilbert C. S., et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 69: 119–128
   PubMed Web of Science ®Google Scholar
• Reed J. C., Haldar S., Croce C. M., et al. Complemenlalion by bcl-2 and c-Ha-ras oncogenes in malignant transformation of rat embryo fibroblasts. Mol Cell Biol 1990; 10: 4370–4374
   PubMed Web of Science ®Google Scholar
• Miyashita T., Reed J. C. bcl-2 transfer increases relative resistance of S491 and WEHI72 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res 1992; 52: 5407–5411
   PubMed Web of Science ®Google Scholar
• Sinha A. A., Blackard C. E., Seal U. S. A critical analysis of lumor morphology and hormone Ireatments in the untrealed and estrogentreated responsive and refractory human prostatic carcinoma. Cancer 1977; 40: 2836–2850
   PubMedGoogle Scholar
• McDonnell T. J., Troncoso P., Brisbay S. M., et al. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 1992; 52: 6940–6944
   PubMed Web of Science ®Google Scholar
• Levine A. J., Perry M. E., Chang A., et al. The role of the p53 tumour-suppressor gene in tumorigenesis. Br J Cancer 1994; 69: 409–416
   PubMed Web of Science ®Google Scholar
• Hollstein M., Sidransky D., Vogelstein B., et al. p53 mutations in human cancer. Science 1991; 253: 49–53
   PubMed Web of Science ®Google Scholar
• Levine A. J., Momand J., Finlay C. A. The p53 tumour suppressor gene. Nature 1991; 351: 453–456
   PubMed Web of Science ®Google Scholar
• Yonish-Rouach E., Resnitzky D., Loteni J., et al. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 1991; 352: 345–347
   PubMed Web of Science ®Google Scholar
• Shaw P., Bovey R., Tardy S., et al. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci USA 1992; 89: 4495–4499
   PubMed Web of Science ®Google Scholar
• Gerwin B. I., Spillare E., Forrester K., et al. Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor β1. Proc Natl Acad Sci USA 1992; 89: 2759–2763
   PubMed Web of Science ®Google Scholar
• Oberhammer F. A., Pavelka M., Sharma S., et al. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1. Proc Natl Acad Sci USA 1992; 89
   PubMed Web of Science ®Google Scholar
• Gottlieb E., Haffner R., von-Ruden T., et al. Down-regulation of wild-type p53 activity interferes with apoplosis of IL-3-dependent hemopoietic cells following IL-3 withdrawal. EMBO J 1994; 13: 1368–1374
   PubMed Web of Science ®Google Scholar
• Zhu Y. M., Bradbury D. A., Russell N. H. Wild-type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukaemic cells. Br J Cancer 1994; 69: 468–472
   PubMed Web of Science ®Google Scholar
• Bates R. C., Buret A., van-Helden D. F., et al. Apoptosis induced by inhibition of intercellular contacl. J Cell Biol 1994; 125: 403–415
   PubMed Web of Science ®Google Scholar
• Selvakumaran M., Lin H. K., Miyashila T., et al. Immediate early regulation of bax expression by p53 but not TGF beta 1: A paradigm for distinct apoptotic pathways. Oncogene 1994; 9: 1791–1798
   PubMed Web of Science ®Google Scholar
• Miyashita T., Krajewski S., Krajewska M., et al. Tumor suppressor p53 is a regulator of bcl-2 and box gene expression in vitro and in vivo. Oncogene 1994; 9: 1799–1805
   PubMed Web of Science ®Google Scholar
• Korsmeyer S. J., Shutter J. R., Veis D. J., et al. bcl-2/bax: A rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 1993; 4: 327–332
   PubMed Web of Science ®Google Scholar
• Lowe S. W., Ruley H. E., Jacks T., et al. p53-dependent apoptosis modulates the cytotoxicity of anticancer drugs. Cell 1993; 74: 957–967
   PubMed Web of Science ®Google Scholar
• Fujiwara T., Grimm E. A., Mukhopadhyay T., et al. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res 1994; 54: 2287–2291
   PubMed Web of Science ®Google Scholar
• Clarke A. R., Gledhill S., Hooper M. L., et al. p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. Oncogene 1994; 9: 1767–1773
   PubMed Web of Science ®Google Scholar
• McCarthy S. A., Symonds H. S., Van-Dyke T. Regulation of apoptosis in transgenic mice by simian virus 40 T antigen-mediated inactivation of p53. Proc Natl Acad Sci USA 1994; 91: 3979–3983
   PubMed Web of Science ®Google Scholar
• Livingstone L. R., White A., Sprouse J., et al. Altered cell cycle arrest and gene amplification potential accompany loss of wild type p53. Cell 1992; 70: 923–935
   PubMed Web of Science ®Google Scholar
• Wyllie A. H. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: Anoverview. Cancer Metas Rev 1992; 11: 95–103
   PubMed Web of Science ®Google Scholar
• Knight C. RL, Rees R. C., Griffin M. Apoplosis: A potential role for cytosolic transglutaminase and its importance in tumour progression. Biochim Biophys Acta 1991; 1096: 312–318
   PubMed Web of Science ®Google Scholar
• Rao L., Debbas M., Sabbatini P., et al. The adenovirus E1 A proteins induce apoplosis which is inhibited by the E1B 19kDa and Bcl-2 proteins. Proc Natl Acad Sci USA 1992; 89: 7742–7746
   PubMed Web of Science ®Google Scholar
• Lowe S. W., Jacks T., Housman D. E., et al. Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc Natl Acad Sci USA 1994; 91: 2026–2030
   PubMed Web of Science ®Google Scholar
• Luster M. I., Blank J. A., Dean J. H. Molecular and cellular basis of chemically induced immunotoxicity. Annu Rev Toxicol 1987; 27: 23–49
   PubMed Web of Science ®Google Scholar
• Dean J. H., Luster M. I., Boorman G. A., et al. Immune suppression following exposure of mice to the carcinogen benzo[a]pyrene but not the noncarcinogenic benzo[e]pyrene. Clin Exp Immunol 1983; 52: 199–206
   PubMed Web of Science ®Google Scholar
• White K. L., Jr, Holsapple M. P. Direct suppressionof in vitro antibody production by mouse spleen cells by the carcinogen benzo[a]pyrene but not by the noncarcinogen cogener benzo[e]pyrene. Cancer Res 1984; 44: 3388–3393
   PubMed Web of Science ®Google Scholar
• Karimi M., Patierno S. R., Manning F. CR. Induction of apoptotic cell death by brefeldin A in human and hamster cells. Proc Am Assoc Cancer Res 1995; 36: 36
   Google Scholar
• Zhan Q. TC, Fan S., Bae I., et al. Induction of box by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene 1994; 9: 3743–3751
   PubMed Web of Science ®Google Scholar
• Miyashita T., Reed J. C. Tumor suppressor p53 is a direct transcriptional activator of the human box gene. Cell 1995; 80: 293–299
   PubMed Web of Science ®Google Scholar
• Boise L. H., Gottschalk A. R., Quintans J., et al. Bcl-2 and Bcl-2-related proteins in apoplosis regulation. Curr Topics Microbiol Immunol 1995; 200: 107–121
   PubMedGoogle Scholar
• Craig R. W. The bcl-2 gene family. Semin. Cancer Biol 1995; 6: 35–43
   PubMed Web of Science ®Google Scholar
• Knudson C. M., Tung K. S., Tourtellote W. G., et al. bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 1995; 270: 96–99
   PubMed Web of Science ®Google Scholar
• Krajewski S., Blomquist C., Franssila K., et al. Reduced expression of poor response rates to combination chemotherapy and shorter survival in women with metastatic breast ademnocarcinoma. Cancer Res 1995; 55: 4471–4478
   PubMed Web of Science ®Google Scholar